Cavitary pneumonia and empyema thoracis caused by multidrug resistant Nocardia otitidiscaviarum in an elderly patient
Rev Esp Quimioter. 2023 Nov 14:perez14nov2023. doi: 10.37201/req/042.2023. Online ahead of print.NO ABSTRACTPMID:37960833 | DOI:10.37201/req/042.2023 (Source: Revista Espanola de Quimioterapia)
Source: Revista Espanola de Quimioterapia - November 14, 2023 Category: Drugs & Pharmacology Authors: I S P érez Ramos M L Gurruchaga Yanes D Fern ández Vecilla U Oiartzabal Elorriaga M J Unzaga Bara ñano J L D íaz de Tuesta Del Arco Source Type: research
Cavitary pneumonia and empyema thoracis caused by multidrug resistant Nocardia otitidiscaviarum in an elderly patient
Rev Esp Quimioter. 2023 Nov 14:perez14nov2023. doi: 10.37201/req/042.2023. Online ahead of print.NO ABSTRACTPMID:37960833 | DOI:10.37201/req/042.2023 (Source: Revista Espanola de Quimioterapia)
Source: Revista Espanola de Quimioterapia - November 14, 2023 Category: Drugs & Pharmacology Authors: I S P érez Ramos M L Gurruchaga Yanes D Fern ández Vecilla U Oiartzabal Elorriaga M J Unzaga Bara ñano J L D íaz de Tuesta Del Arco Source Type: research
Unresolved issues in the diagnosis of catheter related candidemia: A position paper
Rev Esp Quimioter. 2023 Nov 13:soriano13nov2023. doi: 10.37201/req/112.2023. Online ahead of print.ABSTRACTThe incidence and recent trends of candidemia and the contribution of the COVID-19 pandemic to its evolution are not well documented. The catheter is a major focus of Candida spp. infections, but the methods used to confirm the origin of candidemia are still based on the data generated for bacterial infection. The presence of Candida spp. on the tip of a removed catheter is the gold standard for confirmation but it is not always possible to remove it. Conservative methods, without catheter removal, have not been speci...
Source: Revista Espanola de Quimioterapia - November 13, 2023 Category: Drugs & Pharmacology Authors: A Soriano-Mart ín P Mu ñoz J Garc ía-Rodríguez R Cant ón A Vena M Bassetti E Bouza Source Type: research
Rapid AST: Possibility of inferring resistance mechanisms with complex phenotypes
Rev Esp Quimioter. 2023 Nov 8:ligero08nov2023. doi: 10.37201/req/043.2023. Online ahead of print.ABSTRACTThe new automated systems designed for rapid performance of AST have significantly reduced the response time for susceptibility testing of microorganisms causing bacteremia and sepsis. The Accelerate Pheno® system (AAC) is one such system. Our objective for this study was to determine whether the AAC system is capable of providing an accurate susceptibility profile to infer resistance mechanisms in different carbapenemase-producing isolates when compared to the MicroScan WalkAway System (MWS). Disk diffusion method was...
Source: Revista Espanola de Quimioterapia - November 8, 2023 Category: Drugs & Pharmacology Authors: J Ligero-L ópez I Falces-Romero A Aranda-D íaz D Garc ía-Ballesteros J Garc ía-Rodríguez E Cendejas-Bueno Source Type: research
Rapid AST: Possibility of inferring resistance mechanisms with complex phenotypes
Rev Esp Quimioter. 2023 Nov 8:ligero08nov2023. doi: 10.37201/req/043.2023. Online ahead of print.ABSTRACTThe new automated systems designed for rapid performance of AST have significantly reduced the response time for susceptibility testing of microorganisms causing bacteremia and sepsis. The Accelerate Pheno® system (AAC) is one such system. Our objective for this study was to determine whether the AAC system is capable of providing an accurate susceptibility profile to infer resistance mechanisms in different carbapenemase-producing isolates when compared to the MicroScan WalkAway System (MWS). Disk diffusion method was...
Source: Revista Espanola de Quimioterapia - November 8, 2023 Category: Drugs & Pharmacology Authors: J Ligero-L ópez I Falces-Romero A Aranda-D íaz D Garc ía-Ballesteros J Garc ía-Rodríguez E Cendejas-Bueno Source Type: research
Rapid AST: Possibility of inferring resistance mechanisms with complex phenotypes
Rev Esp Quimioter. 2023 Nov 8:ligero08nov2023. doi: 10.37201/req/043.2023. Online ahead of print.ABSTRACTThe new automated systems designed for rapid performance of AST have significantly reduced the response time for susceptibility testing of microorganisms causing bacteremia and sepsis. The Accelerate Pheno® system (AAC) is one such system. Our objective for this study was to determine whether the AAC system is capable of providing an accurate susceptibility profile to infer resistance mechanisms in different carbapenemase-producing isolates when compared to the MicroScan WalkAway System (MWS). Disk diffusion method was...
Source: Revista Espanola de Quimioterapia - November 8, 2023 Category: Drugs & Pharmacology Authors: J Ligero-L ópez I Falces-Romero A Aranda-D íaz D Garc ía-Ballesteros J Garc ía-Rodríguez E Cendejas-Bueno Source Type: research
Rapid AST: Possibility of inferring resistance mechanisms with complex phenotypes
Rev Esp Quimioter. 2023 Nov 8:ligero08nov2023. doi: 10.37201/req/043.2023. Online ahead of print.ABSTRACTThe new automated systems designed for rapid performance of AST have significantly reduced the response time for susceptibility testing of microorganisms causing bacteremia and sepsis. The Accelerate Pheno® system (AAC) is one such system. Our objective for this study was to determine whether the AAC system is capable of providing an accurate susceptibility profile to infer resistance mechanisms in different carbapenemase-producing isolates when compared to the MicroScan WalkAway System (MWS). Disk diffusion method was...
Source: Revista Espanola de Quimioterapia - November 8, 2023 Category: Drugs & Pharmacology Authors: J Ligero-L ópez I Falces-Romero A Aranda-D íaz D Garc ía-Ballesteros J Garc ía-Rodríguez E Cendejas-Bueno Source Type: research
Concerning the presumptive identification of Candida kefyr on Uriselect ™4 agar
CONCLUSIONS: This study provides the first description of the specific behavior of C. kefyr on UriSelect™4 agar, which differentiates it from other Candida species based on its enzymatic characteristics.PMID:37925628 | DOI:10.37201/req/068.2023 (Source: Revista Espanola de Quimioterapia)
Source: Revista Espanola de Quimioterapia - November 5, 2023 Category: Drugs & Pharmacology Authors: E G ómez-Vicente J M Navarro-Mar í E Rodr íguez-Guerrero A Rosales-Castillo jR Guti érrez-Fernández Source Type: research
Concerning the presumptive identification of Candida kefyr on Uriselect ™4 agar
CONCLUSIONS: This study provides the first description of the specific behavior of C. kefyr on UriSelect™4 agar, which differentiates it from other Candida species based on its enzymatic characteristics.PMID:37925628 | DOI:10.37201/req/068.2023 (Source: Revista Espanola de Quimioterapia)
Source: Revista Espanola de Quimioterapia - November 5, 2023 Category: Drugs & Pharmacology Authors: E G ómez-Vicente J M Navarro-Mar í E Rodr íguez-Guerrero A Rosales-Castillo jR Guti érrez-Fernández Source Type: research
Concerning the presumptive identification of Candida kefyr on Uriselect ™4 agar
CONCLUSIONS: This study provides the first description of the specific behavior of C. kefyr on UriSelect™4 agar, which differentiates it from other Candida species based on its enzymatic characteristics.PMID:37925628 | DOI:10.37201/req/068.2023 (Source: Revista Espanola de Quimioterapia)
Source: Revista Espanola de Quimioterapia - November 5, 2023 Category: Drugs & Pharmacology Authors: E G ómez-Vicente J M Navarro-Mar í E Rodr íguez-Guerrero A Rosales-Castillo jR Guti érrez-Fernández Source Type: research
Tuberculosis in Spain: An opinion paper
Rev Esp Quimioter. 2023 Nov 2:moreno02nov2023. doi: 10.37201/req/115.2023. Online ahead of print.ABSTRACTThis document is the result of the deliberations of the Committee on Emerging Pathogens and COVID-19 of the Illustrious Official College of Physicians of Madrid (ICOMEM) regarding the current situation of tuberculosis, particularly in Spain. We have reviewed aspects such as the evolution of its incidence, the populations currently most exposed and the health care circuits for the care of these patients in Spain. We have also discussed latent tuberculosis, the reality of extrapulmonary disease in the XXI century and the ...
Source: Revista Espanola de Quimioterapia - November 3, 2023 Category: Drugs & Pharmacology Authors: S Moreno Guill én F J Rodr íguez-Artalejo J Ruiz-Galiana R Cant ón P De Lucas Ramos A Garc ía-Botella A Garc ía-Lledó T Hern ández-Sampelayo J G ómez-Pavón J Gonz ález Del Castillo M C Mart ín-Delgado F J Mart ín Sánchez M Mart ínez-Sellés Source Type: research
Tuberculosis in Spain: An opinion paper
Rev Esp Quimioter. 2023 Nov 2:moreno02nov2023. doi: 10.37201/req/115.2023. Online ahead of print.ABSTRACTThis document is the result of the deliberations of the Committee on Emerging Pathogens and COVID-19 of the Illustrious Official College of Physicians of Madrid (ICOMEM) regarding the current situation of tuberculosis, particularly in Spain. We have reviewed aspects such as the evolution of its incidence, the populations currently most exposed and the health care circuits for the care of these patients in Spain. We have also discussed latent tuberculosis, the reality of extrapulmonary disease in the XXI century and the ...
Source: Revista Espanola de Quimioterapia - November 3, 2023 Category: Drugs & Pharmacology Authors: S Moreno Guill én F J Rodr íguez-Artalejo J Ruiz-Galiana R Cant ón P De Lucas Ramos A Garc ía-Botella A Garc ía-Lledó T Hern ández-Sampelayo J G ómez-Pavón J Gonz ález Del Castillo M C Mart ín-Delgado F J Mart ín Sánchez M Mart ínez-Sellés Source Type: research
In vitro activity of cefiderocol and other newly approved antimicrobials against multi-drug resistant Gram-negative pathogens recovered in intensive care units in Spain and Portugal
CONCLUSIONS: Our results are in agreement with other studies performed outside Spain and Portugal highlighting its excellent activity against MDR gram-negative bacteria. Cefiderocol is a therapeutic alternative to those available for the treatment of infections caused by these MDR bacteria.PMID:37882320 | DOI:10.37201/req/098.2023 (Source: Revista Espanola de Quimioterapia)
Source: Revista Espanola de Quimioterapia - October 26, 2023 Category: Drugs & Pharmacology Authors: D Gij ón J Garc ía-Castillo M C Fern ández-López G Bou M Siller J Calvo-Montes C Pitart J Vila N Torno C Gimeno H Cruz H Ramos X Mulet A Oliver P Ruiz-Garbajosa R Canton Source Type: research
In vitro activity of cefiderocol and other newly approved antimicrobials against multi-drug resistant Gram-negative pathogens recovered in intensive care units in Spain and Portugal
CONCLUSIONS: Our results are in agreement with other studies performed outside Spain and Portugal highlighting its excellent activity against MDR gram-negative bacteria. Cefiderocol is a therapeutic alternative to those available for the treatment of infections caused by these MDR bacteria.PMID:37882320 | DOI:10.37201/req/098.2023 (Source: Revista Espanola de Quimioterapia)
Source: Revista Espanola de Quimioterapia - October 26, 2023 Category: Drugs & Pharmacology Authors: D Gij ón J Garc ía-Castillo M C Fern ández-López G Bou M Siller J Calvo-Montes C Pitart J Vila N Torno C Gimeno H Cruz H Ramos X Mulet A Oliver P Ruiz-Garbajosa R Canton Source Type: research
In vitro activity of cefiderocol and other newly approved antimicrobials against multi-drug resistant Gram-negative pathogens recovered in intensive care units in Spain and Portugal
CONCLUSIONS: Our results are in agreement with other studies performed outside Spain and Portugal highlighting its excellent activity against MDR gram-negative bacteria. Cefiderocol is a therapeutic alternative to those available for the treatment of infections caused by these MDR bacteria.PMID:37882320 | DOI:10.37201/req/098.2023 (Source: Revista Espanola de Quimioterapia)
Source: Revista Espanola de Quimioterapia - October 26, 2023 Category: Drugs & Pharmacology Authors: D Gij ón J Garc ía-Castillo M C Fern ández-López G Bou M Siller J Calvo-Montes C Pitart J Vila N Torno C Gimeno H Cruz H Ramos X Mulet A Oliver P Ruiz-Garbajosa R Canton Source Type: research
